IP Library Granted Patent US 6,916,303
Granted Patent B2
US 6,916,303 · App. 10/073,084 · Granted Jul 12, 2005

Photoreduction method for hemoglobin-vesicle

Assignee: Japan Science and Technology Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,916,303
App. No.
10/073,084
Granted
Jul 12, 2005
Kind
B2
Abstract

A method and an apparatus for regenerating an oxygen-binding ability by reducing the methemoglobin contained in hemoglobin-vesicle by light irradiation. This method includes adding electron donors such as amino acids, saccharides, alcohols, and/or flavin derivatives in appropriate amounts to the inner aqueous phase of the hemoglobin-vesicle, applying light to the vesicle when the content of methemoglobin increases as a result of oxidation of hemoglobin, thereby reducing the metohemoglobin. In this manner, the oxygen-binding ability is recovered, thereby maintaining the function of the hemoglobin-vesicle.

Claims (13)

1. A method of regenerating a lowered oxygen binding ability of a hemoglobin-vesicle suspension used for injection as an oxygen infusion into a blood supply, comprising:

using, as the hemoglobin-vesicle suspension, a phospholipid vesicle which includes the aqueous hemoglobin solution therein and an electron donor in an inner aqueous phase thereof; and

irradiating the hemoglobin-vesicle suspension, upon withdrawal and separation of the hemoglobin-vesicle suspension from the blood supply, with light when hemoglobin in the hemoglobin-vesicle suspension is oxidized into methemoglobin and lose its oxygen biding ability, thereby reducing methemoglobin into hemoglobin to regenerate the oxygen binding ability.

2. The apparatus for carrying out the method according to claim 1 , comprising:

means for taking the blood and the hemoglobin-vesicle suspension out of a living body, said taking occurring after the hemoglobin-vesicle defined in claim 1 is intravenously administered to the living body and the oxygen-binding ability of the hemoglobin-vesicle is lowered by generation of methemoglobin;

means for isolating the hemoglobin-vesicle from the blood obtained by the means for taking blood;

means for irradiating the hemoglobin-vesicle with light in order to regenerate the oxygen-binding ability of the hemoglobin-vesicle separated; and

means for returning the hemoglobin-vesicle which has regenerated its oxygen-binding ability into the living body.

3. The apparatus according to claim 2 , further comprising:

means for removing oxygen from the hemoglobin-vesicle isolated from the blood.

4. The method according to claim 1 , wherein said electron donor is selected from the group consisting of amino acids, saccharides, alcohols and flavin derivatives.

5. The method according to claim 1 , further comprising:

removing oxygen from the hemoglobin-vesicle suspension prior to the irradiating step.

Assignments (5)
CORPORATE DISOLUTION Recorded Jul 25, 2005
From: JAPAN SCIENCE AND TECHNOLOGY CORPORATION
To: JAPAN SCIENCE AND TECHNOLOGY CORPORATION
Reel/Frame 016570/0400 →
ESTABLISHMENT OF INDEPENDENT ADMINISTRATIVE INSTITUTION BY JAPANESE GOVERNMENT,SUCCESSIVE TO GOVERNMENTAL CORPORATION AND TRANSFER OF RIGHTS Recorded Jul 25, 2005
From: JAPAN SCIENCE AND TECHNOLOGY CORPORATION
To: JAPAN SCIENCE AND TECHNOLOGY AGENCY
Reel/Frame 016570/0405 →
INCORPORATION OF INDEPENDENT ADMINISTRATIVE INSTITUTION Recorded Jul 25, 2005
From: JAPAN SCIENCE AND TECHNOLOGY AGENCY
To: JAPAN SCIENCE AND TECHNOLOGY AGENCY
Reel/Frame 016570/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2005
From: JAPAN SCIENCE AND TECHNOLOGY AGENCY
To: WASEDA UNIVERSITY
Reel/Frame 016573/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2002
From: TSUCHIDA, EISHUN; SAKAI, HIROMI; ONUMA, HIROTO; TAKEOKA, SHINJI
To: JAPAN SCIENCE AND TECHNOLOGY CORPORATION
Reel/Frame 012584/0216 →
Priority Claims (1)
JP 2000-175611 · Jun 12, 2000 · national
Continuity (2)
Continuation PCTJP000919800 · Dec 25, 2000
Related Publication 20020095108A1 · Jul 18, 2002